Shanghai ZJ Bio-Tech Co. Ltd. A Market Cap ($456.98 Million)
Market Cap & Net Worth: Shanghai ZJ Bio-Tech Co. Ltd. A (688317)
Shanghai ZJ Bio-Tech Co. Ltd. A market cap. Shanghai ZJ Bio-Tech Co. Ltd. A (SHG:688317) has a market capitalization of $456.98 Million (CN¥3.12 Billion) as of November 8, 2026. Listed on the SHG stock exchange, this China-based company holds position #12367 globally and #3600 in its home market, demonstrating a -1.67% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shanghai ZJ Bio-Tech Co. Ltd. A's stock price CN¥16.45 by its total outstanding shares 189843712 (189.84 Million). Also see 688317 cash flow metrics for how efficiently the company converts equity into cash flow.
Shanghai ZJ Bio-Tech Co. Ltd. A Market Cap History (2021–2026)
Shanghai ZJ Bio-Tech Co. Ltd. A market cap history from 2021 to 2026. Data shows change from $1.32 Billion to $456.98 Million (-21.52% CAGR). Check Shanghai ZJ Bio-Tech Co. Ltd. A stock price for real-time trading data and today's change.
Shanghai ZJ Bio-Tech Co. Ltd. A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shanghai ZJ Bio-Tech Co. Ltd. A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Shanghai ZJ Bio-Tech Co. Ltd. A (688317) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
4.49x
Shanghai ZJ Bio-Tech Co. Ltd. A's market cap is 4.49 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $1.32 Billion | $2.02 Billion | $758.52 Million | 0.65x | 1.74x |
| 2022 | $879.62 Million | $2.33 Billion | $760.27 Million | 0.38x | 1.16x |
| 2023 | $579.01 Million | $274.33 Million | -$136.86 Million | 2.11x | N/A |
| 2024 | $451.43 Million | $178.65 Million | -$127.46 Million | 2.53x | N/A |
| 2025 | $560.32 Million | $124.91 Million | -$34.30 Million | 4.49x | N/A |
Competitor Companies of 688317 by Market Capitalization
Companies near Shanghai ZJ Bio-Tech Co. Ltd. A in the global market cap rankings as of November 8, 2026. Also see 688317 current and non-current assets for a full breakdown of the balance sheet.
Key companies related to Shanghai ZJ Bio-Tech Co. Ltd. A by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #109 globally with a market cap of $191.15 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #188 globally with a market cap of $124.99 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #222 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #109 | Abbott Laboratories | NYSE:ABT | $191.15 Billion | $109.93 |
| #188 | Stryker Corporation | NYSE:SYK | $124.99 Billion | $325.87 |
| #222 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $101.80 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Shanghai ZJ Bio-Tech Co. Ltd. A (2021–2026)
Market capitalization of Shanghai ZJ Bio-Tech Co. Ltd. A from 2021 to today. Between 2021 and today, Shanghai ZJ Bio-Tech Co. Ltd. A's market cap moved from $1.32 Billion to $ 456.98 Million, with a yearly change of -21.52%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥456.98 Million | -18.44% |
| 2025 | CN¥560.32 Million | +24.12% |
| 2024 | CN¥451.43 Million | -22.03% |
| 2023 | CN¥579.01 Million | -34.18% |
| 2022 | CN¥879.62 Million | -33.19% |
| 2021 | CN¥1.32 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 8th, 2026 the market cap of Shanghai ZJ Bio-Tech Co. Ltd. A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $456.98 Million USD |
| MoneyControl | $456.98 Million USD |
| MarketWatch | $456.98 Million USD |
| marketcap.company | $456.98 Million USD |
| Reuters | $456.98 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shanghai ZJ Bio-Tech Co. Ltd. A
Shanghai ZJ Bio-Tech Co., Ltd. engages in the research and development, production, and sale of molecular diagnostic reagents and instruments in China and internationally. The company offers nucleic acid and real-time PCR kits, as well as consumables. It serves public health safety and clinical diagnostics sectors. The company was founded in 2005 and is based in Shanghai, China.